tegafur has been researched along with Symptom Cluster in 5 studies
Excerpt | Relevance | Reference |
---|---|---|
"A 42-year-old woman with reversible splenial lesion syndrome (RESLES) and rectal adenocarcinoma presented with sudden-onset delirium after the sixth cycle of her chemotherapy drug, oral tegafur-uracil (300 mg/m/day, days 1-14, with treatment cycle repeated every 21 days)." | 7.96 | Reversible Splenial Lesion Syndrome (RESLES) After Chemotherapy of Oral Tegafur-uracil in a Female With Locally Rectal Adenocarcinoma. ( Bi, QQ; Chen, YJ; Ge, YX; Lin, YY, 2020) |
"Uracil/tegafur was stopped in December 10, 2005, and docetaxel (taxotere) 50mg/m2 was given in December 12, 2005." | 5.34 | [Hand-foot syndrome associated with uracil/tegafur and docetaxel in a patient with lung cancer]. ( Bandoh, S; Kanaji, N, 2007) |
"A 42-year-old woman with reversible splenial lesion syndrome (RESLES) and rectal adenocarcinoma presented with sudden-onset delirium after the sixth cycle of her chemotherapy drug, oral tegafur-uracil (300 mg/m/day, days 1-14, with treatment cycle repeated every 21 days)." | 3.96 | Reversible Splenial Lesion Syndrome (RESLES) After Chemotherapy of Oral Tegafur-uracil in a Female With Locally Rectal Adenocarcinoma. ( Bi, QQ; Chen, YJ; Ge, YX; Lin, YY, 2020) |
" Also, as the veins in the lower extremity were filled with thrombus, we gave him an anticoagulant (Edoxaban), but due to the malignant hyper coagulable state (Trousseau syndrome) a CV port could not be implanted." | 3.91 | [A Case Report of Luminal A Male Inflammatory Breast Cancer that Was Difficult to Treat Because of Trousseau Syndrome]. ( Hirai, A; Ichiki, Y; Imanishi, N; Ishida, T; Kusanagi, K; Shinohara, S; Takeda, Y; Tanaka, F; Tashima, Y; Yoshimatsu, K, 2019) |
"Uracil/tegafur was stopped in December 10, 2005, and docetaxel (taxotere) 50mg/m2 was given in December 12, 2005." | 1.34 | [Hand-foot syndrome associated with uracil/tegafur and docetaxel in a patient with lung cancer]. ( Bandoh, S; Kanaji, N, 2007) |
"We treated a recurrent gastric cancer patient with chronic renal failure who developed grade 2 HFS, grade 2 conjunctivitis and grade 3 stomatitis soon after TS-1 administration." | 1.32 | [A patient with recurrent gastric cancer who developed TS-1 induced hand-foot syndrome]. ( Arai, K; Honma, S; Iwasaki, Y; Kimura, Y; Takahashi, K; Takahashi, T; Yamaguchi, T, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Ge, YX | 1 |
Lin, YY | 1 |
Bi, QQ | 1 |
Chen, YJ | 1 |
Tashima, Y | 1 |
Kusanagi, K | 1 |
Takeda, Y | 1 |
Yoshimatsu, K | 1 |
Ishida, T | 1 |
Shinohara, S | 1 |
Hirai, A | 1 |
Imanishi, N | 1 |
Ichiki, Y | 1 |
Tanaka, F | 1 |
Arai, K | 1 |
Iwasaki, Y | 1 |
Kimura, Y | 1 |
Takahashi, K | 1 |
Yamaguchi, T | 1 |
Honma, S | 1 |
Takahashi, T | 1 |
Kanaji, N | 1 |
Bandoh, S | 1 |
Camps, C | 1 |
Soler, JJ | 1 |
Godes, MJ | 1 |
Pujol, C | 1 |
Febrer, MI | 1 |
5 other studies available for tegafur and Symptom Cluster
Article | Year |
---|---|
Reversible Splenial Lesion Syndrome (RESLES) After Chemotherapy of Oral Tegafur-uracil in a Female With Locally Rectal Adenocarcinoma.
Topics: Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Brain Diseases; Female; Humans; Rectal Neopl | 2020 |
[A Case Report of Luminal A Male Inflammatory Breast Cancer that Was Difficult to Treat Because of Trousseau Syndrome].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms, Male; Cilostazol; Combined M | 2019 |
[A patient with recurrent gastric cancer who developed TS-1 induced hand-foot syndrome].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Conjunctivitis; Drug Combinations; Foot Derma | 2003 |
[Hand-foot syndrome associated with uracil/tegafur and docetaxel in a patient with lung cancer].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administratio | 2007 |
[Cutaneous toxicity by ftorafur, hand-foot or palmar-plantar erythrodysesthesia syndrome].
Topics: Female; Foot Dermatoses; Humans; Middle Aged; Syndrome; Tegafur | 1991 |